Econometric modelling of multiple self-reports of health states: the switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · see citing works

Untitled work

(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544 · see citing works

Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets

van Hout, B., Janssen, M. F., Feng, Y.-S., Kohlmann, T., Busschbach, J., Golicki, D., Lloyd, A., Scalone, L., Kind, P., & Pickard, A. S. (2012) · Value in Health · doi:10.1016/j.jval.2012.02.008 · Cited by 2,153 · see citing works

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study

Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., Swinburn, P., & Busschbach, J. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0322-4 · Cited by 1,582 · see citing works

Vines--a new graphical model for dependent random variables

Bedford, T., & Cooke, R. (2002) · The Annals of Statistics · doi:10.1214/aos/1031689016 · Cited by 1,456 · see citing works

Valuing health-related quality of life: an EQ-5D-5L value set for England

Devlin, N. J., Shah, K. K., Feng, Y., Mulhern, B., & van Hout, B. (2018) · Health Economics · doi:10.1002/hec.3564 · Cited by 1,356 · see citing works

EQ-5D and the EuroQol group: past, present and future

Devlin, N. J., & Brooks, R. (2017) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0310-5 · Cited by 1,189 · see citing works

The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study

Cross, M., Smith, E. U. R., Hoy, D. G., Carmona, L., Wolfe, F., Vos, T., Williams, B., Gabriel, S. E., Lassere, M. N., Johns, N. E., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204627 · Cited by 1,157 · see citing works

Dutch Tariff for the Five-Level Version of EQ-5D

M. Versteegh, M., M. Vermeulen, K., M. A. A. Evers, S., de Wit, G. A., Prenger, R., & A. Stolk, E. (2016) · Value in Health · doi:10.1016/j.jval.2016.01.003 · Cited by 1,113 · see citing works

Copula Modeling: An Introduction for Practitioners

Trivedi, P. K., & Zimmer, D. M. (2007) · Foundations and Trends® in Econometrics · doi:10.1561/0800000005 · Cited by 878 · see citing works

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

Claxton, K., Martin, S., Soares, M. O., Rice, N., Spackman, E., Hinde, S., Devlin, N. J., Smith, P., & Sculpher, M. J. (2015) · Health Technology Assessment · doi:10.3310/hta19140 · Cited by 859 · see citing works

The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation.

Bruce, B., & Fries, J. F. (2003) · PubMed · Cited by 753 · see citing works

A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures

Brazier, J. E., Yang, Y., Tsuchiya, A., & Rowen, D. (2009) · The European Journal of Health Economics · doi:10.1007/s10198-009-0168-z · Cited by 517 · see citing works

A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada

Xie, F., Pullenayegum, E., Gaebel, K., Bansback, N. J., Bryan, S., Ohinmaa, A. E., Poissant, L., & Johnson, J. A. (2015) · Medical Care · doi:10.1097/mlr.0000000000000447 · Cited by 448 · see citing works

The EQ-5D-5L valuation study in Korea

Kim, S., Ahn, J., Ock, M., Shin, S., Park, J., Luo, N., & Jo, M. (2016) · Quality of Life Research · doi:10.1007/s11136-015-1205-2 · Cited by 393 · see citing works

Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms

Choi, E. P. H., Lam, C. L. K., & Chin, W. (2014) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-12-1 · Cited by 331 · see citing works

Psychometric Comparison of the Standard EQ-5D to a 5 Level Version in Cancer Patients

Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007) · Medical Care · doi:10.1097/01.mlr.0000254515.63841.81 · Cited by 259 · see citing works

Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping

Gray, A. M., Rivero‐Arias, O., & Clarke, P. (2006) · Medical Decision Making · doi:10.1177/0272989x05284108 · Cited by 222 · see citing works

Pair copula constructions for multivariate discrete data

Panagiotelis, A., Czado, C., & Joe, H. (2012) · Journal of the American Statistical Association · doi:10.1080/01621459.2012.682850 · Cited by 194 · see citing works

Tails from the Peak District: Adjusted Limited Dependent Variable Mixture Models of EQ-5D Questionnaire Health State Utility Values

Alava, M. H., Wailoo, A., & Ara, R. (2012) · Value in Health · doi:10.1016/j.jval.2011.12.014 · Cited by 182 · see citing works

Developing a Japanese version of the EQ-5D-5L value set

Ikeda, S., Shiroiwa, T., Igarashi, A., Noto, S., Fukuda, T., Saito, S., & Shimozuma, K. (2015) · Hoken iryou kagaku · Cited by 156 · see citing works

Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population

Agborsangaya, C. B., Lahtinen, M., Cooke, T., & Johnson, J. A. (2014) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-12-74 · Cited by 152 · see citing works

Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases

Scalone, L., Ciampichini, R., FAGIUOLI, S., Gardini, I., Fusco, F., Gaeta, L. M., Prete, A. D., Cesana, G., & Mantovani, L. G. (2012) · Quality of Life Research · doi:10.1007/s11136-012-0318-0 · Cited by 135 · see citing works

The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank.

Wolfe, F., & Michaud, K. (2011) · Rheumatology · doi:10.1093/rheumatology/keq155 · Cited by 134 · see citing works

Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis

Choy, E., Smith, C. M., Farewell, V. T., Walker, D., HASSELL, A. B., Chau, L., & Scott, D. L. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076299 · Cited by 126 · see citing works

An EQ-5D-5L value set based on Uruguayan population preferences

Augustovski, F., Rey‐Ares, L., Irazola, V. E., Garay, O. U., Gianneo, Ó., Fernández, G., Morales, M., Gibbons, L., & Ramos-Goñi, J. M. (2015) · Quality of Life Research · doi:10.1007/s11136-015-1086-4 · Cited by 99 · see citing works

Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY

Brazier, J. E., & Tsuchiya, A. (2015) · Applied Health Economics and Health Policy · doi:10.1007/s40258-015-0194-1 · Cited by 96 · see citing works

Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B

Jia, Y., Cui, F., Li, L., Zhang, D. L., Zhang, G. M., Wang, F. Z., Gong, X. H., Zheng, H., Wu, Z. H., Miao, N., et al. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0670-3 · Cited by 90 · see citing works

New methods for modelling EQ-5D-5L value sets: An application to English data

Feng, Y., Devlin, N. J., Shah, K. K., Mulhern, B. J., & van Hout, B. (2017) · Health Economics · doi:10.1002/hec.3560 · Cited by 82 · see citing works

Should Linking Replace Regression When Mapping from Profile-Based Measures to Preference-Based Measures?

Fayers, P. M., & Hays, R. D. (2014) · Value in Health · doi:10.1016/j.jval.2013.12.002 · Cited by 64 · see citing works

Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis

Wailoo, A., Alava, M. H., Scott, I. C., Ibrahim, F., & Scott, D. L. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu039 · Cited by 26 · see citing works

Prediction of Patient-Reported Outcome Measures Via Multivariate Ordered Probit Models

Conigliani, C., Manca, A., & Tancredi, A. (2014) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/rssa.12072 · Cited by 17 · see citing works

Bicop: A Command for Fitting Bivariate Ordinal Regressions with Residual Dependence Characterized by a Copula Function and Normal Mixture Marginals

Alava, M. H., & Pudney, S. E. (2016) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x1601600114 · Cited by 14 · see citing works

Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study

Alava, M. H., Pudney, S. E., & Wailoo, A. (2022) · PharmacoEconomics · doi:10.1007/s40273-022-01218-7 · Cited by 220 · see citing works

An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values

Mukuria, C., Rowen, D., Harnan, S., Rawdin, A. C., Wong, R., Ara, R., & Brazier, J. E. (2019) · Applied Health Economics and Health Policy · doi:10.1007/s40258-019-00467-6 · Cited by 116 · see citing works

Value Sets for EQ-5D-5L

Devlin, N. J., Roudijk, B., & Ludwig, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-89289-0 · Cited by 99 · see citing works

EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom

Alava, M. H., Wailoo, A., Grimm, S. E., Pudney, S. E., Gomes, M., Sadique, Z., Meads, D. M., O'Dwyer, J. L., Barton, G., & Irvine, L. (2017) · Value in Health · doi:10.1016/j.jval.2017.09.004 · Cited by 89 · see citing works

Severity-Adjusted Probability of Being Cost Effective

Versteegh, M., Ramos, I. C., Büyükkaramikli, N., Ansaripour, A., Reckers‐Droog, V., & Brouwer, W. B. F. (2019) · PharmacoEconomics · doi:10.1007/s40273-019-00810-8 · Cited by 84 · see citing works

Eq5Dmap: A Command for Mapping between EQ-5D-3L and EQ-5D-5L

Alava, M. H., & Pudney, S. E. (2018) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x1801800207 · Cited by 59 · see citing works

Mapping EQ-5D-3L to EQ-5D-5L

van Hout, B. A., & Shaw, J. W. (2021) · Value in Health · doi:10.1016/j.jval.2021.03.009 · Cited by 56 · see citing works

Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review

Keetharuth, A. D., Hussain, H., Rowen, D., & Wailoo, A. (2022) · Health and Quality of Life Outcomes · doi:10.1186/s12955-022-02036-3 · Cited by 54 · see citing works

Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.

Alava, M. H., Wailoo, A., Pudney, S., Gray, L., & Manca, A. (2020) · Health Technology Assessment · doi:10.3310/hta24340 · Cited by 38 · see citing works

Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets

Law, E. H., Pickard, A. S., Xie, F., Walton, S. M., Lee, T. A., & Schwartz, A. (2018) · Medical Decision Making · doi:10.1177/0272989x18802797 · Cited by 34 · see citing works

Disease progression of alpha-mannosidosis and impact on patients and carers – A UK natural history survey

Adam, J., Malone, R., Lloyd, S., Lee, J., Hendriksz, C. J., & Ramaswami, U. (2019) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2019.100480 · Cited by 30 · see citing works

The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals

Pennington, B., Alava, M. H., Pudney, S. E., & Wailoo, A. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0701-y · Cited by 29 · see citing works

An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness Analysis

Wailoo, A., Alava, M. H., Pudney, S. E., Barton, G., O'Dwyer, J. L., Gomes, M., Irvine, L., Meads, D. M., & Sadique, Z. (2021) · Value in Health · doi:10.1016/j.jval.2020.11.012 · Cited by 26 · see citing works

Guidance to Users of EQ-5D-5L Value Sets

Devlin, N. J., Finch, A. P., & Parkin, D. W. (2022) · Springer eBooks · doi:10.1007/978-3-030-89289-0_5 · Cited by 25 · see citing works

Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data

Alava, M. H., & Pudney, S. E. (2022) · Health Economics · doi:10.1002/hec.4487 · Cited by 24 · see citing works

A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions

Shaw, J. W., Bennett, B. L., Trigg, A., DeRosa, M., Taylor, F. C., Kiff, C., Ntais, D., Noon, K., King, M. T., & Cocks, K. (2021) · Value in Health · doi:10.1016/j.jval.2021.05.022 · Cited by 23 · see citing works

Obstetric brachial plexus injuries (OBPIs): health-related quality of life in affected adults and parents

Yau, C. W. H., Pizzo, E., Prajapati, C., Draycott, T. J., & Lenguerrand, E. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-1039-z · Cited by 22 · see citing works

Health utilities and costs for neuromyelitis optica spectrum disorder

Hughes, D. A., Bourke, S., Jones, A., Bhatt, R., Huda, S., Mutch, K., & Jacob, A. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02310-z · Cited by 22 · see citing works

Disability and multidimensional quality of life: A capability approach to health status assessment.

Anand, P., Roope, L., Culyer, A., & Smith, R. (2020) · Health Economics · doi:10.1002/hec.4017 · Cited by 14 · see citing works

Psychometric Performance of the EQ Health and Wellbeing Short in a United Kingdom Population Sample

McDool, E., Mukuria, C., & Peasgood, T. (2024) · Value in Health · doi:10.1016/j.jval.2024.05.007 · Cited by 16 · see citing works

The Use of Oral Analgesics and Pain Self-Efficacy Are Independent Predictors of the Quality of Life of Individuals with Rheumatoid Arthritis

Hashimoto, A., Sonohata, M., & Mawatari, M. (2020) · Pain Research and Management · doi:10.1155/2020/7409396 · Cited by 14 · see citing works

Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis

Thokala, P., Si, P. E. H., Alava, M. H., Sasso, A., Schaufler, T., Soro, M., & Fotheringham, J. (2023) · PharmacoEconomics · doi:10.1007/s40273-022-01237-4 · Cited by 12 · see citing works

eq5d: Methods for Analysing 'EQ-5D' Data and Calculating 'EQ-5D' Index Scores

Morton, F. J., & Nijjar, J. S. (2019) · doi:10.32614/cran.package.eq5d · Cited by 11 · see citing works

Multivariate multilevel modeling of quality of life dynamics of HIV infected patients

Dessie, Z. G., Zewotir, T. T., Mwambi, H. G., & North, D. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01330-2 · Cited by 10 · see citing works

Health-Related Quality of Life in Patients with Health Conditions in Lebanese Community Setting

Dimassi, H. I., Nasser, S. C., Issa, A., Adrian, S. S., & Hazimeh, B. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168817 · Cited by 9 · see citing works

Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape

Querol, L., Rinaldi, S., Borsi, A., Boggia, G. M., de Courcy, J. J., Taylor, Y., Wright, J., Karmous, W., Noël, W., Gary, C., et al. (2025) · Journal of the Peripheral Nervous System · doi:10.1111/jns.70047 · Cited by 8 · see citing works

Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial

Messelink, M. A., van der Leeuw, M. S., den Broeder, A. A., Tekstra, J., van der Goes, M. C., Heijstek, M. W., Lafeber, F. P. J. G., & Welsing, P. M. J. (2022) · Trials · doi:10.1186/s13063-022-06471-x · Cited by 8 · see citing works

Use of removable support boot versus cast for early mobilisation after ankle fracture surgery: cost-effectiveness analysis and qualitative findings of the Ankle Recovery Trial (ART)

Baji, P., Barbosa, E. C., Heaslip, V., Sangar, B., Tbaily, L., Martin, R., Docherty, S., Allen, H., Hayward, C. J., & Marques, E. M. R. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-073542 · Cited by 8 · see citing works

Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme

Scott, D., Ibrahim, F., Hill, H., Tom, B., Prothero, L., Baggott, R. R., Bosworth, A., Galloway, J., Georgopoulou, S., Martin, N., et al. (2021) · Programme Grants for Applied Research · doi:10.3310/pgfar09080 · Cited by 3 · see citing works

Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey

Stenson, K., Fecteau, T. E., O’Callaghan, L., Bryden, P., Mellor, J., Wright, J., Earl, L., Thomas, O., Iqbal, H., Barlow, S. G., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-023-12141-y · Cited by 7 · see citing works

Basic versions of the EQ-5D questionnaire as standard international instruments for assessing the quality of life in metropolis. Short Review

Andreev, D. A., Zavyalov, A. A., & Kashurnikov, A. Y. (2021) · City Healthcare · doi:10.47619/2713-2617.zm.2021.v2i1;62-69 · Cited by 7 · see citing works

The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial

Morgan, K., Man, M., Bloomer, R., Cochrane, M., Cole, M., Dheensa, S., Eisenstadt, N., Feder, G. S., Gaunt, D., Leach, R., et al. (2023) · Trials · doi:10.1186/s13063-023-07612-6 · Cited by 7 · see citing works

Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data

Neilson, A. R., Jones, G. T., Macfarlane, G. J., Pathan, E., & McNamee, P. (2022) · The European Journal of Health Economics · doi:10.1007/s10198-022-01429-x · Cited by 6 · see citing works

Cost Effectiveness of Local Anaesthetic Transperineal Versus Transrectal Biopsy: Results from the TRANSLATE Study

Little, M., Wolstenholme, J. L., Landeiro, F., Marian, I. R., Williams, R., López, J. F. J., Mercader, C., Raslan, M., Berridge, C., Whitburn, J., et al. (2025) · European Urology Focus · doi:10.1016/j.euf.2025.11.007 · Cited by 4 · see citing works

The clinical and cost effectiveness of internet-delivered self-help Acceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS): Study protocol for a randomised controlled trial with ethnically diverse family carers

Kishita, N., Gould, R. L., McCracken, L. M., Khondoker, M., Turner, D. A., Ashford, P.-A., Flanagan, E., Czyznikowska, B., Richmond, E., Riggey, M., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107685 · Cited by 3 · see citing works

The natural course of health-related quality of life in patients with clinically suspect arthralgia: a longitudinal study in progressors and non-progressors to rheumatoid arthritis

Bour, S. S., Goossens, L. M. A., Khidir, S. J. H., de Jong, P. H. P., Mil, A. H. M. V. D. H., Mölken, M. R., & van Mulligen, E. (2025) · Rheumatology International · doi:10.1007/s00296-025-05865-9 · Cited by 3 · see citing works

More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review’s Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis

Langley, P. C. (2020) · INNOVATIONS in pharmacy · doi:10.24926/iip.v11i1.2402 · Cited by 3 · see citing works

To what extent does the use of crosswalks instead of EQ-5D value sets impact reimbursement decisions?: a simulation study

Ben, Â. J., van Dongen, J. M., Finch, A. P., Alili, M. E., & Bosmans, J. E. (2022) · The European Journal of Health Economics · doi:10.1007/s10198-022-01539-6 · Cited by 3 · see citing works

COMPARISON OF EQ-5D-3L AND EQ-5D-5L FOR HEALTH-RELATED QUALITY OF LIFE MEASUREMENT IN INDONESIAN POPULATION WITH SEVERAL CONDITIONS

Endarti, D., Kristina, S. A., Noorizzati, R., Nugraha, A. E., Maharani, F., Putri, K. A., Azizah, A. H., Angganisaputri, S., & Yustikarini, Y. (2019) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.1008241 · Cited by 2 · see citing works

Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective

Coughlan, D., Arisa, O., Thomson, K. H., Yu, G., Pearson, F., Kernohan, A., Gonzalez-Moral, S. G., Wallace, S. A., & Rice, S. J. C. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01317-z · Cited by 2 · see citing works

Cost-Effectiveness of an Extended-Role General Practitioner Clinic for Persistent Physical Symptoms: Results From the Multiple Symptoms Study 3 Pragmatic Randomized Controlled Trial

Neilson, A. R., Mooney, C., Sutton, L., White, D. A., Dawson, J., Rowlands, G., Thomas, R. E., Woodward, J., Deary, V., & Burton, C. D. (2024) · Value in Health · doi:10.1016/j.jval.2024.09.015 · Cited by 2 · see citing works

A standard gamble study to determine health state utilities associated with seizures in glioma in the UK

Robinson, T., Breckons, M., Bulbeck, H., Jenkinson, M. D., Grant, R., & Vale, L. D. (2025) · Health and Quality of Life Outcomes · doi:10.1186/s12955-025-02348-0 · Cited by 2 · see citing works

A feasibility trial of an intervention in alcohol dependence for structured preparation before detoxification versus usual care: the SPADe trial results

Kouimtsidis, C., Houghton, B., Gage, H., Notley, C. J., Maskrey, V., Clark, A., Holland, R., Lingford-Hughes, A. R., Punukollu, B., Touray, M., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00880-6 · Cited by 2 · see citing works

Dose Correlation of Panax ginseng and Atractylodes macrocephala Koidz. Drug Pairs in the Chinese Medicine Prescription Based on the Copula Function

Lin, W., Zheng, M., Chen, Y., He, Q., Khoja, A. A., Long, M., Fan, J., Hao, Y., Fu, C., Hu, P., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9933254 · Cited by 2 · see citing works

Software Updates

(2022) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x221083931 · Cited by 2 · see citing works

Yet another Ersatz World: The ICER Final Evidence Report for Additive Cardiovascular Therapies

Langley, P. C. (2019) · INNOVATIONS in pharmacy · doi:10.24926/iip.v10i4.2337 · Cited by 2 · see citing works

Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making

Maervoet, J., & Bergemann, R. (2025) · Value in Health · doi:10.1016/j.jval.2025.03.015 · Cited by 1 · see citing works

Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel

Chase, D. M., Herrstedt, J., Miller, E. M., Gilbert, L., Zub, O., Mathews, C. A., Angioli, R., Teneriello, M. G., Gropp‐Meier, M., Powell, M. A., et al. (2025) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2025.101935 · Cited by 1 · see citing works

Gabapentin as an adjunct to multimodal pain regimens in surgical patients: the GAP placebo-controlled RCT and economic evaluation

Baos, S., Walker-Smith, T., Lui, M., Stokes, E. A., Jiang, J., Pufulete, M., Gibbison, B., & Rogers, C. A. (2025) · Health Technology Assessment · doi:10.3310/plmh9787 · Cited by 1 · see citing works

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adults: results from the cross-sectional observational EAGLE study

Williams, P. R., Herring, T. A., Yokota, R. T. C., Venkatesan, S., Arnetorp, S., Severens, J. L., Powell, P. A., Marcus, J. C., Philpott, S., Bestea, S., et al. (2026) · BMJ Public Health · doi:10.1136/bmjph-2024-001865 · Cited by 1 · see citing works

Sensor Data-Driven Personalised Hip and Knee Replacement Rehabilitation Compared to Standard of Care, Pilot Randomized Trial

McNamara, I., Whitehouse, C. E., Ward, N., Hodgins, D., & Whalley, R. (2023) · British journal of healthcare and medical research · doi:10.14738/bjhmr.105.15420 · Cited by 1 · see citing works

Health Related Quality of Life in Patients with Chronic Disease in Lebanese Community SettingPreprint

Dimassi, H. I., Nasser, S. C., Issa, A., Aderian, S. S., & Hazimeh, B. (2020) · Research Square · doi:10.21203/rs.3.rs-70060/v1

Medición de la calidad de vida de pacientes con artritis reumatoide atendidos en el Hospital Universitario del Caribe, Bolívar, Colombia

Rodríguez-Cantillo, J., López, J.-F., Ibarra, J. P., Grau, Á. M., Alvis‐Guzmán, N., & Zakzuk, J. (2021) · Revista Ciencias Biomédicas · doi:10.32997/rcb-2021-3667

Clinical outcomes

Scott, D. L. (2020) · doi:10.1093/med/9780198831433.003.0042

Selection of mixed copula for association modeling with tied observations

Li, Y., Wang, F., Shen, Y., Qin, Y., & Si, J. (2022) · Statistical Methods & Applications · doi:10.1007/s10260-022-00628-3

Mavacamten (Camzyos)

CADTH (2023) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2023.670

Health State Utility Values in Fabry Disease: Insights from the Pegunigalsidase Alfa Clinical Trials

Azimpour, K., Dorling, P., Koulinska, I. N., Kunduri, S., Lan, Z., Poritz, J., Tremblay, G., & Raad, A. (2025) · Advances in Therapy · doi:10.1007/s12325-024-03095-2

Additional file 1 of Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review

Keetharuth, A. D., Hussain, H., Rowen, D., & Wailoo, A. (2022) · Figshare · doi:10.6084/m9.figshare.21228859

Additional file 1 of Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial

Messelink, M. A., van der Leeuw, M. S., DenBroeder, A., Tekstra, J., van der Goes, M. C., Heijstek, M. W., Lafeber, F. P. J. G., & Welsing, P. M. J. (2022) · Figshare · doi:10.6084/m9.figshare.20086136

Additional file 1 of The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial

Morgan, K., Man, M.-S., Bloomer, R., Cochrane, M., Cole, M., Dheensa, S., Eisenstadt, N., Feder, G. S., Gaunt, D., Leach, R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24217472

Clinical Profile, Humanistic and Economic Burden of Paroxysmal Nocturnal Hemoglobinuria in Patients Treated With C5 Inhibitors

Gandhi, S., Radsak, M. P., Ueda, Y., Balp, M., Wiyani, A., Somenzi, O., Snellman, J., Taylor, Y., Simons, A., & Panse, J. P. (2026) · eJHaem · doi:10.1002/jha2.70248

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study

Williams, P. R., Herring, T. A., Yokota, R. T. C., Venkatesan, S., Bergenheim, K., Severens, J. L., Powell, P. A., Marcus, J. C., Philpott, S., Bestea, S., et al. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1771834

Physician and Patient Perception of Disease, Symptomatology, and Treatment Administration Preference in Paroxysmal Nocturnal Haemoglobinuria: Results from a Real-World Survey

Han, B., Balp, M., Snellman, J., Wiyani, A., Amporful, G. C., Hatchell, N., Taylor, Y., Weatherby, S., Che, S., Cruz, J., et al. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03749-3

Mapping between EQ-5D-5L and EQ-5D-3L in lumbar spine surgery patients: Machine learning compared to crosswalk algorithms

Chang, N. H. S., Pedersen, C. F., Andersen, M. Ø., & Carreon, L. Y. (2026) · Brain and Spine · doi:10.1016/j.bas.2026.107459

Copula-based modelling of self-reported health states: an application to the use of EQ-5D-3L and EQ-5D-5L in evaluating drug therapies for rheumatic diseasePreprint

Pudney, S., & Hernandez-Alava, M. (n.d.) · RePEc: Research Papers in Economics

EQ-5D-5L versus 3L: the impact on cost-effectiveness

Alava, M. H., Wailoo, A., Grimm, S., Pudney, S. E., Gomes, M., Sadique, Z., Meads, D., O'Dwyer, J. L., Barton, G., & Irvine, L. (2017) · Cited by 1 · see citing works

EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom

Alava, M. H., Wailoo, A., Grimm, S. E., Pudney, S. E., Gomes, M., Sadique, Z., Meads, D. M., O'Dwyer, J. L., Barton, G., & Irvine, L. (2017) · Value in Health · doi:10.1016/j.jval.2017.09.004 · Cited by 89 · see citing works

Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study

Alava, M. H., Pudney, S. E., & Wailoo, A. (2022) · PharmacoEconomics · doi:10.1007/s40273-022-01218-7 · Cited by 220 · see citing works

Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data

Alava, M. H., & Pudney, S. E. (2022) · Health Economics · doi:10.1002/hec.4487 · Cited by 24 · see citing works